Company / SG&A per Share
NEUROONE MEDICAL TECHNOLOGIES Corp SG&A per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.26
FY2025
5-year range
$0.26 / $0.64
FY2021-FY2025
Trend
-11.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 4 consecutive years, from $0.64 in FY2021 to $0.26 in FY2025.
Based on SEC 10-K filings.
0.26 in FY2025 with a 10-year CAGR of +42.9%.
Improved from $0.43 to $0.26 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -21.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- +42.9%
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's sg&a per share has declined for 4 consecutive years.
- In FY2025, sg&a per share decreased 11.4% year-over-year.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | -11.4% |
| FY2024 | $0.29 | -32.7% |
| FY2023 | $0.43 | -17.4% |
| FY2022 | $0.52 | -18.9% |
| FY2021 | $0.64 | +10448.9% |
| FY2016 | $0.01 | -15.7% |
| FY2015 | $0.01 | +39.3% |
| FY2014 | $0.01 | -14.2% |
| FY2012 | $0.01 | +277.5% |
| FY2011 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026